C32.3
C32.3: Malignant neoplasm of laryngeal cartilage
Billable / specific codeICD-10-CM
C32.3 is a billable, specific ICD-10-CM code for malignant neoplasm of laryngeal cartilage. It is valid for submission on a claim.
Check C32.3 with the rest of the claim: free scrubberOther codes that can never be billed with C32.3
Their own Excludes1 notes name this code, so the conflict is not listed above.
Risk adjustment
C32.3 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 21 Lymphoma and Other Cancers0.671 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C32.3 is named in 57 Medicare coverage policies: 57 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A54111Billing and Coding: Speech Language Pathology (SLP) Services: Communication Disorders
Code history
Unchanged in every release from FY2024 to FY2027.